-
1
-
-
0031864727
-
Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro
-
10.1097/00008390-199806000-00005 1:CAS:528:DyaK1cXkslKrsbw%3D 9664144
-
E Auzenne ME Leroux M Hu RE Pollock B Feig J Klostergaard 1998 Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro Melanoma Res 8 227 239 10.1097/00008390- 199806000-00005 1:CAS:528:DyaK1cXkslKrsbw%3D 9664144
-
(1998)
Melanoma Res
, vol.8
, pp. 227-239
-
-
Auzenne, E.1
Leroux, M.E.2
Hu, M.3
Pollock, R.E.4
Feig, B.5
Klostergaard, J.6
-
2
-
-
0035881074
-
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
-
1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
-
CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit ID Fleming JE Gershenwald A Houghton Jr JM Kirkwood KM McMasters MF Mihm DL Morton DS Reintgen MI Ross A Sober JA Thompson JF Thompson 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
-
(2001)
J Clin Oncol
, vol.19
, pp. 3635-3648
-
-
Balch, C.M.1
Buzaid, A.C.2
Soong, S.J.3
Atkins, M.B.4
Cascinelli, N.5
Coit, D.G.6
Fleming, I.D.7
Gershenwald, J.E.8
Houghton, Jr.A.9
Kirkwood, J.M.10
McMasters, K.M.11
Mihm, M.F.12
Morton, D.L.13
Reintgen, D.S.14
Ross, M.I.15
Sober, A.16
Thompson, J.A.17
Thompson, J.F.18
-
3
-
-
0035880957
-
Prognostic factors analysis of 17, 600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
-
1:STN:280:DC%2BD3MvlvV2ktA%3D%3D 11504744
-
CM Balch SJ Soong JE Gershenwald JF Thompson DS Reintgen N Cascinelli M Urist KM McMasters MI Ross JM Kirkwood MB Atkins JA Thompson DG Coit D Byrd R Desmond Y Zhang PY Liu GH Lyman A Morabito 2001 Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622 3634 1:STN:280: DC%2BD3MvlvV2ktA%3D%3D 11504744
-
(2001)
J Clin Oncol
, vol.19
, pp. 3622-3634
-
-
Balch, C.M.1
Soong, S.J.2
Gershenwald, J.E.3
Thompson, J.F.4
Reintgen, D.S.5
Cascinelli, N.6
Urist, M.7
McMasters, K.M.8
Ross, M.I.9
Kirkwood, J.M.10
Atkins, M.B.11
Thompson, J.A.12
Coit, D.G.13
Byrd, D.14
Desmond, R.15
Zhang, Y.16
Liu, P.Y.17
Lyman, G.H.18
Morabito, A.19
-
4
-
-
70349479218
-
Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines
-
10.1158/1535-7163.MCT-09-0377 1:CAS:528:DC%2BD1MXhtFCis7jJ 19723881
-
MA Bill C Bakan DM Benson Jr J Fuchs G Young GB Lesinski 2009 Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines Mol Cancer Ther 8 2726 2735 10.1158/1535-7163.MCT-09-0377 1:CAS:528:DC%2BD1MXhtFCis7jJ 19723881
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 2726-2735
-
-
Bill, M.A.1
Bakan, C.2
Benson, Jr.D.M.3
Fuchs, J.4
Young, G.5
Lesinski, G.B.6
-
5
-
-
0035842333
-
Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53
-
10.1006/excr.2001.5381 1:CAS:528:DC%2BD3MXosFGhs7c%3D 11716543
-
JA Bush KJ Cheung Jr G Li 2001 Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53 Exp Cell Res 271 305 314 10.1006/excr.2001.5381 1:CAS:528:DC%2BD3MXosFGhs7c%3D 11716543
-
(2001)
Exp Cell Res
, vol.271
, pp. 305-314
-
-
Bush, J.A.1
Cheung, Jr.K.J.2
Li, G.3
-
6
-
-
70349325677
-
Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway
-
Cao C, Huang X, Han Y, Wan Y, Birnbaumer L, Feng GS, Marshall J, Jiang M, Chu WM (2009) Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal 2:ra17
-
(2009)
Sci Signal
, vol.2
-
-
Cao, C.1
Huang, X.2
Han, Y.3
Wan, Y.4
Birnbaumer, L.5
Feng, G.S.6
Marshall, J.7
Jiang, M.8
Chu, W.M.9
-
7
-
-
46749105482
-
Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles
-
10.1007/s11095-008-9614-3 1:CAS:528:DC%2BD1cXot1WhsLk%3D 18480968
-
D Deshpande H Devalapally M Amiji 2008 Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles Pharm Res 25 1936 1947 10.1007/s11095-008-9614-3 1:CAS:528:DC%2BD1cXot1WhsLk%3D 18480968
-
(2008)
Pharm Res
, vol.25
, pp. 1936-1947
-
-
Deshpande, D.1
Devalapally, H.2
Amiji, M.3
-
8
-
-
0025820745
-
Cutaneous melanoma
-
10.1056/NEJM199107183250306 1:STN:280:DyaK3M3ntVegsg%3D%3D 1805813
-
HK Koh 1991 Cutaneous melanoma N Engl J Med 325 171 182 10.1056/NEJM199107183250306 1:STN:280:DyaK3M3ntVegsg%3D%3D 1805813
-
(1991)
N Engl J Med
, vol.325
, pp. 171-182
-
-
Koh, H.K.1
-
9
-
-
34648847350
-
Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells
-
10.1097/CMR.0b013e3282ed3d0e 1:CAS:528:DC%2BD2sXhtVKhtLbL 17885582
-
YE Marin BA Wall S Wang J Namkoong JJ Martino J Suh HJ Lee AB Rabson CS Yang S Chen JH Ryu 2007 Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells Melanoma Res 17 274 283 10.1097/CMR.0b013e3282ed3d0e 1:CAS:528:DC%2BD2sXhtVKhtLbL 17885582
-
(2007)
Melanoma Res
, vol.17
, pp. 274-283
-
-
Marin, Y.E.1
Wall, B.A.2
Wang, S.3
Namkoong, J.4
Martino, J.J.5
Suh, J.6
Lee, H.J.7
Rabson, A.B.8
Yang, C.S.9
Chen, S.10
Ryu, J.H.11
-
10
-
-
0033054696
-
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide
-
10.1016/S0145-2126(99)00048-X 1:CAS:528:DyaK1MXktVSkurw%3D 10374850
-
D Myrick D Blackinton J Klostergaard N Kouttab A Maizel H Wanebo S Mehta 1999 Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide Leuk Res 23 569 578 10.1016/S0145-2126(99)00048-X 1:CAS:528:DyaK1MXktVSkurw%3D 10374850
-
(1999)
Leuk Res
, vol.23
, pp. 569-578
-
-
Myrick, D.1
Blackinton, D.2
Klostergaard, J.3
Kouttab, N.4
Maizel, A.5
Wanebo, H.6
Mehta, S.7
-
11
-
-
34547619923
-
Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells
-
1:CAS:528:DC%2BD28XhtFSisrrE 16969513
-
L Qiu C Zhou Y Sun W Di E Scheffler S Healey H Wanebo N Kouttab W Chu Y Wan 2006 Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells Oncol Rep 16 907 913 1:CAS:528:DC%2BD28XhtFSisrrE 16969513
-
(2006)
Oncol Rep
, vol.16
, pp. 907-913
-
-
Qiu, L.1
Zhou, C.2
Sun, Y.3
Di, W.4
Scheffler, E.5
Healey, S.6
Wanebo, H.7
Kouttab, N.8
Chu, W.9
Wan, Y.10
-
12
-
-
0027355755
-
Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances
-
1:CAS:528:DyaK3sXmtFKls7Y%3D 8379450
-
NS Radin JA Shayman J Inokuchi 1993 Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances Adv Lipid Res 26 183 213 1:CAS:528:DyaK3sXmtFKls7Y%3D 8379450
-
(1993)
Adv Lipid Res
, vol.26
, pp. 183-213
-
-
Radin, N.S.1
Shayman, J.A.2
Inokuchi, J.3
-
13
-
-
0029984475
-
The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
-
10.1016/S0190-9622(96)90041-9 1:STN:280:DyaK283gvFajsA%3D%3D 8632084
-
DS Rigel RJ Friedman AW Kopf 1996 The incidence of malignant melanoma in the United States: issues as we approach the 21st century J Am Acad Dermatol 34 839 847 10.1016/S0190-9622(96)90041-9 1:STN:280:DyaK283gvFajsA%3D%3D 8632084
-
(1996)
J Am Acad Dermatol
, vol.34
, pp. 839-847
-
-
Rigel, D.S.1
Friedman, R.J.2
Kopf, A.W.3
-
14
-
-
73149088865
-
An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells
-
10.1124/mol.109.059105 1:CAS:528:DC%2BD1MXhsFajtb%2FF 19779032
-
L Wang Y Shen R Song Y Sun J Xu Q Xu 2009 An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells Mol Pharmacol 76 1238 1245 10.1124/mol.109.059105 1:CAS:528:DC%2BD1MXhsFajtb%2FF 19779032
-
(2009)
Mol Pharmacol
, vol.76
, pp. 1238-1245
-
-
Wang, L.1
Shen, Y.2
Song, R.3
Sun, Y.4
Xu, J.5
Xu, Q.6
|